Pricing

Robert Kim

Chief Medical Officer at ViewPoint Therapeutics, Inc.

Robert Kim

Robert Kim

Chief Medical Officer at ViewPoint Therapeutics, Inc.

Overview

RelSci Relationships

1872

Relationships

View Relationship Details

RelSci Relationships are individuals Robert Kim likely has professional access to. A relationship does not necessarily indicate a personal connection.

Leah Makley

President, Chief Executive Officer & Director at ViewPoint Therapeutics, Inc.

Relationship likelihood: Strong

Ed Hurwitz

Chairman at ViewPoint Therapeutics, Inc.

Relationship likelihood: Strong

Harry K. Genant

Executive Director & Professor-Emeritus at University of California - San Francisco

Relationship likelihood: Average

David A. Kessler

Professor at University of California - San Francisco

Relationship likelihood: Average

John Stephens Downs

Executive Director, Finance & Administration, University Development & Alumni Relations at UCSF Foundation

Relationship likelihood: Average

Jaime Sepulveda

Executive Director, Global Health Sciences at University of California - San Francisco

Relationship likelihood: Average

Peter R. Carroll

Professor & Chairman, Department of Urology at University of California - San Francisco

Relationship likelihood: Average

John D. B. Featherstone

Dean, School of Dentistry at University of California - San Francisco

Relationship likelihood: Average

Sam Hawgood

President at UCSF Foundation

Relationship likelihood: Average

Daniel H. Lowenstein

Executive Vice Chancellor & Provost at University of California - San Francisco

Relationship likelihood: Average

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

RelSci

May 2, 2018

Robert Kim is now serving in a new position at ViewPoint Therapeutics, Inc.

GlobeNewswire

May 1, 2018

ViewPoint Appoints Dr. Robert Kim as Chief Medical Officer

PR Newswire

August 8, 2016

Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer

Paths to Robert Kim

Potential Connections via
Relationship Science

You

Robert Kim

Chief Medical Officer at ViewPoint Therapeutics, Inc.

Career History

Chief Medical Officer

2018 - Current

ViewPoint Therapeutics, Inc.

Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA.

Associate Clinical Professor of Ophthalmology

Current

University of California - San Francisco

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Chief Medical Officer

2016 - Prior

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Crestwood, KY.

Transactions

Details Hidden

Apellis Pharmaceuticals, Inc. raised money in a private placement transaction

Other Affiliations

Robert Kim is affiliated with ViewPoint Therapeutics, Inc., University of California - San Francisco, Apellis Pharmaceuticals, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Kim. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Kim's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Kim.